Navigation Links
UF McKnight Brain Institute director honored by Italian scientists
Date:7/8/2008

GAINESVILLE, Fla. Dennis Steindler, executive director of the Evelyn F. and William L. McKnight Brain Institute of the University of Florida, was honored for his contributions to neuroscience at a ceremony with officials from the Catholic University in Rome, the university's teaching hospital the Gemelli University Polyclinic and the Italian government.

Steindler received the Atena Onlus Foundation Award in Rome in June for his research in adult stem cell biology and regenerative medicine.

Sharing the award were Dr. Gianfranco Rossi, a pioneering neurophysiologist who founded the neurosurgery program at the Catholic University; and professor Rita Levi-Montalcini, who won the Nobel Prize in Physiology and Medicine in 1986 for her work involving brain growth factors.

"The secret of the enormous advances in treating brain diseases is the alliance of biologists and neurosurgeons," Steindler said while accepting the award. "Biologists are excited by discoveries regarding stem cells and the possibility to regenerate brain tissue, but there is always the vital need for clinicians to come to the aid of patients. These must be complementary efforts."

Steindler was nominated for the award by professor Julius Maira, M.D., the director and chairman of the neurosurgery institute at the Catholic University and Gemelli University Polyclinic. The hospital is widely known for treating Pope John Paul II's medical conditions from 1981 to 2005.

"I expect that all the strands that we are following will lead to results soon in the fields of malignant brain tumors, intracranial aneurysms, neural stem cells and reconstructive surgery," Maira said.

Former Italian ministers of health Livia Turkish and Girolamo Sirchia attended the ceremony, as did Monsignor Achille Silvestrini and Monsignor Vincenzo Paglia, both bishops in Italian dioceses.

"It is humbling to receive the award and an honor to share it with such gift
'/>"/>

Contact: John Pastor
jdpastor@ufl.edu
352-273-5815
University of Florida
Source:Eurekalert  

Page: 1 2

Related medicine news :

1. Intrepid USA Healthcare Services Appoints Kathy McKnight as Chief Operations Officer
2. Draining away brains toxic protein to stop Alzheimers
3. Vision restoration therapy shown to improve brain activity in brain injured patients
4. Clinical depression linked to abnormal emotional brain circuits
5. Brain imaging reveals breakdown of normal emotional processing
6. Brain cells work differently than previously thought
7. Vaccine Stops Alzheimers Brain Tangles
8. Research may unlock mystery of autisms origin in the brain
9. Scientists Spot Brains Free Will Center
10. Free will takes flight: how our brains respond to an approaching menace
11. Alcoholics With Cirrhosis Have More Brain Damage

Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
UF McKnight Brain Institute director honored by Italian scientists
UF McKnight Brain Institute director honored by Italian scientists
(Date:11/30/2009)...ues increase by 247%, - Net loss reduced signi...rstCall/ - CRH Medical Corporation (CRM:TSX-V) ann...ine months ended September 30, 2009 (all figures a...d September 30, 2009, the Company reported a net l... for the three months ended September 30, 2008, an...
(Date:11/30/2009)...Newswire-FirstCall/ - AIM Health Group Inc. ("AIM"...d health care company, announced today that its ne...r 30, 2009 (the "Quarter") increased to $633,199 f...e time EBITDA(1) increased 290% to $910,734 from $...any also announced that revenues increased 87% to ...
(Date:11/30/2009)...ignificant impact, CBO analysis understates the ef...wire/ -- The Blue Cross and Blue Shield Associat...ng the estimate released today by the Congressiona...ed what many economists, actuaries, and health pol...care reform bill would make coverage more expensiv...
(Date:11/30/2009)... immune cells than sedentary, healthy adults , ,...udies have shown that exercise can help ward off h...s that the reason why may be found within cells th...omeres -- DNA at the tips of chromosomes that prot...althy, nonsmoking adults who did not exercise regu...
(Date:11/30/2009)...Nov. 30 Jedi Mind, Inc ...ased to announce the Company,s first thought-contr... The game, "Think-Tac-Toe" is the first of its kin... power of their mind and is geared towards people ...ce of $49 and can be purchased directly through th...
Breaking Medicine News(10 mins):Health News:CRH Medical reports Q3 2009 results 2Health News:CRH Medical reports Q3 2009 results 3Health News:AIM Health Group Inc. continues increased quarterly profits 2Health News:AIM Health Group Inc. continues increased quarterly profits 3Health News:AIM Health Group Inc. continues increased quarterly profits 4Health News:CBO Confirms That Premiums Will Increase Under the Senate Healthcare Reform Bill 2Health News:Exercise Guards White Blood Cells Against Aging 2Health News:Exercise Guards White Blood Cells Against Aging 3Health News:First Thought-Controlled Game Complete From Jedi Mind, Inc. 2
...porosis Foundation (NOF) will honor two-time Acade...ly Field; local D.C. celebrities and owners of FLE...d chairman of EmpowHer, Michelle King Robson, at i...ce of Bel-Air" will serve as mistress of ceremonie...
...honors the accomplishments of medical education pr...ouston, TX (PRWEB) May 20, 2009 -- TIAA-CREF, a n...rovider of retirement services in the academic, me...Award ( www.tiaa-crefaward.org ). , , , , ,The TI...
...ess Ten Years After Institute of Medicine Found Up..., Texas, May 20 Ten years ago, the Institute of M...ad toll of medical errors in a groundbreaking repo...shed, little progress has been made implementing k...
...ration (Nasdaq: MDTH ) will host a conference ca...uss results from its second quarter ended March 31...ouncing those results and file its Form 10-Q with ...: 10:00 a.m ET, Friday, May 22, 2009, ...
...s, Inc. (Nasdaq: VSCP ), a leading provider of q...ounced that it has received notification from The ...e with the minimum $1.00 per share bid price requi...ce rule, the Company was required to evidence a cl...
...versity of California, San Francisco and Baystate ...s concludes that patients facing coronary artery b...a medical facility that has the highest adherence ...nces in quality of care might influence outcomes f...
Other Medicine News:Health News:Sally Field, Phil and Jan Fenty, and Michelle King Robson to Be Honored at Benefit for Osteoporosis and Bone Health Awareness 2Health News:Sally Field, Phil and Jan Fenty, and Michelle King Robson to Be Honored at Benefit for Osteoporosis and Bone Health Awareness 3Health News:Sally Field, Phil and Jan Fenty, and Michelle King Robson to Be Honored at Benefit for Osteoporosis and Bone Health Awareness 4Health News:Open Call for Nominations for the Sixth Annual TIAA-CREF Distinguished Medical Educator Award 2Health News:Open Call for Nominations for the Sixth Annual TIAA-CREF Distinguished Medical Educator Award 3Health News:Open Call for Nominations for the Sixth Annual TIAA-CREF Distinguished Medical Educator Award 4Health News:U.S. Health Care System Fails to Protect Patients From Deadly Medical Errors 2Health News:U.S. Health Care System Fails to Protect Patients From Deadly Medical Errors 3Health News:U.S. Health Care System Fails to Protect Patients From Deadly Medical Errors 4Health News:U.S. Health Care System Fails to Protect Patients From Deadly Medical Errors 5Health News:MedCath Corporation to Hold Conference Call on Second Quarter Results 2Health News:VirtualScopics Regains NASDAQ Compliance 2Health News:Quality measures improve outcomes more than hospital volume alone 2Health News:Quality measures improve outcomes more than hospital volume alone 3
(Date:11/30/2009)... , NEW YORK, Nov. 30 Repo...report is available in its catalogue: ,, Decub... Review ,, http://www.reportlinker.com/p01642...e-Market-Review.html ,, Decubitus Ulcers are ...stant pressure of the patient,s bodyweight. Pressu...
(Date:11/30/2009)... , KING OF PRUSSIA, Pa., Nov. 30 /PRNewswire/ -...e completion of a Phase I study of CPSI-2364, its ...duction of TNF-alpha and other pro-inflammatory cy...ose escalation study in healthy volunteers confirm...esting. ,, All 30 enrolled subjects completed...
(Date:11/30/2009)..., CHICAGO, Nov. 30 Dr. Jocelyn R...Intervention at George Washington University Medic...cult lesions identified with Breast-Specific Gamma...odality imaging for needle biopsy as well, as for ...ting of the Radiological Society of North America ...
Breaking Medicine Technology:Reportlinker Adds Decubitus Ulcer Treatment Products - A Worldwide Market Review 2Reportlinker Adds Decubitus Ulcer Treatment Products - A Worldwide Market Review 3Reportlinker Adds Decubitus Ulcer Treatment Products - A Worldwide Market Review 4Reportlinker Adds Decubitus Ulcer Treatment Products - A Worldwide Market Review 5Reportlinker Adds Decubitus Ulcer Treatment Products - A Worldwide Market Review 6Cytokine PharmaSciences Completes Phase I Study of Oral Anti-Inflammatory Agent, CPSI-2364 2Breast-Specific Gamma Imaging Identifies Occult Lesions Using Multi-Modality Imaging for Biopsy 2Korein Tillery 3A Is Time Running Out for the Manufacturers of the Herbicide Atrazine 3F 55156 1Korein Tillery 3A Is Time Running Out for the Manufacturers of the Herbicide Atrazine 3F 55156 2Korein Tillery 3A Is Time Running Out for the Manufacturers of the Herbicide Atrazine 3F 55156 3Kaiser Permanente Named 2009 Company of the Year by LATINA Style Magazine 55154 1Kaiser Permanente Named 2009 Company of the Year by LATINA Style Magazine 55154 2Kaiser Permanente Named 2009 Company of the Year by LATINA Style Magazine 55154 3NIAID to fund new human immune profiling research centers 55152 1NIAID to fund new human immune profiling research centers 55152 2
...(TM) is evaluating zonisamide SR as a novel compon...EGO, June 07, 2007 /PRNewswire-FirstCall/ -- Orexi...ompany focused on the,treatment of central nervous..., today announced results from a Phase I trial eva...proprietary,sustained-release (SR) formulation of...
...ITY, Calif.--(BUSINESS WIRE)--Jun 6, 2007 - Gilead... Study 102, a,Phase III clinical trial evaluating ...ofovir disoproxil fumarate or tenofovir,DF) 300 mg...virus,(HBV) infection, met its primary efficacy en...r to the company,s once-daily antiviral,drug Hepse...
Other Medicine Technology:OREXIGEN Therapeutics Announces Sustained-Release Formulation of,Zonisamide Shows Improved Tolerability When Compared to Immediate,Release Formulation 2OREXIGEN Therapeutics Announces Sustained-Release Formulation of,Zonisamide Shows Improved Tolerability When Compared to Immediate,Release Formulation 3OREXIGEN Therapeutics Announces Sustained-Release Formulation of,Zonisamide Shows Improved Tolerability When Compared to Immediate,Release Formulation 4Phase III Study Evaluating Gilead's Viread for the Treatment of,Chronic Hepatitis B Virus Meets Primary Endpoint 2Phase III Study Evaluating Gilead's Viread for the Treatment of,Chronic Hepatitis B Virus Meets Primary Endpoint 3Phase III Study Evaluating Gilead's Viread for the Treatment of,Chronic Hepatitis B Virus Meets Primary Endpoint 4Phase III Study Evaluating Gilead's Viread for the Treatment of,Chronic Hepatitis B Virus Meets Primary Endpoint 5Phase III Study Evaluating Gilead's Viread for the Treatment of,Chronic Hepatitis B Virus Meets Primary Endpoint 6Phase III Study Evaluating Gilead's Viread for the Treatment of,Chronic Hepatitis B Virus Meets Primary Endpoint 7
Atria 6100
VASOVIEW® HemoPro™ Endoscopic Vessel Harvesting System
PM-9000 Express Patient Monitor
BC-3200 Auto Hematology Analyzer
Medicine Products: